Clinical trials - Press Releases

Date	Title	Company
30-Mar-2022	Tower Cold Chain launches KTEvolution container for pharmaceutical transport	Tower Cold Chain
30-Mar-2022	New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections	Novartis
29-Mar-2022	Freya Pharma Solutions secures US$8.5 million enabling the start of a pivotal phase 3 trial with Lybrido against Female Sexual Interest/Arousal Disorder (FSIAD)	Freya Pharma Solutions
29-Mar-2022	Bone Therapeutics to strategically focus on lead cell therapy product ALLOB	Bone Therapeutics
29-Mar-2022	Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis	Sanofi
28-Mar-2022	TolerogenixX Receives Approval to Start Phase IIb Trial for its Immune Tolerance-Inducing MIC-Lx Cell Therapy	TolerogenixX GmbH
25-Mar-2022	ICR welcomes FDA approval of ‘search and destroy’ treatment	The Institute of Cancer Research
25-Mar-2022	Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody	Tiziana Life Sciences Ltd
25-Mar-2022	XFret Wins the 2021 Sustainability Award – Startup/Small Business Category	TIACA
25-Mar-2022	TIACA Announces the Take-Off of the BlueSky Program	TIACA
25-Mar-2022	Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing	Jazz Pharmaceuticals
25-Mar-2022	Envirotainer’s Releye® RAP container already approved by 10 airlines	Envirotainer
23-Mar-2022	4D pharma announces positive interim results from the Phase I/II study of the combination of MRx0518 and KEYTRUDA(R) (pembrolizumab) for the treatment of renal cell carcinoma	4D pharma
22-Mar-2022	Innovative collaboration to offer heart rhythm checks throughout the North West to detect Atrial Fibrillation via Community Pharmacies	Daiichi Sankyo and O’Brien’s Pharmacies Group
22-Mar-2022	Zygel’s anticipated impact on underserved fragile X syndrome market sees sales estimates of $18.1 million, says GlobalData	Zynerba Pharmaceuticals
22-Mar-2022	Sajid Javid is sticking his head in the sand, expert warns, as long Covid cases mount and immunity falls	London Medical Laboratory
22-Mar-2022	CELL AND GENE THERAPY CATAPULT LAUNCHES 2021 CLINICAL TRIALS DATABASE REPORT	The Cell and Gene Therapy Catapult (CGT Catapult)
22-Mar-2022	Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute	Biocomposites
22-Mar-2022	CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles	CD Bioparticles
16-Mar-2022	Clinical trial team at Royal Berkshire NHS Foundation Trust innovates with SMART on FHIR data automation platform, Archer	IgniteData